14 / 30
Page 32
Notes:
allied
academies
Journal of Neurology and Neurorehabilitation Research | Volume 3
November 26-27, 2018 | Dubai, UAE
Spine and Spine Disorders
Addiction Research and Therapy
3rd International Conference on
International Conference on
Joint Event
&
Lumbar Spinal Canal Stenosis: Paradigm shift towards a targeted reduced decompression
Walter Bini
Waldkrankenhaus Bad Duben, Germany
L
umbar Spinal Stenosis (LSS) is characterized by a narrowing
of the lumbar spinal canal and/or the intervertebral foramina
resulting from disc degeneration, bulging of the annulus,
facet joint hypertrophy and infolding of the ligamentum
flavum. With increase of the aging population and advances
in diagnostic imaging capabilities, lumbar spinal stenosis in
its different stages or types is becoming more frequently
diagnosed with an estimated prevalence of up to 13%. This,
along with newer technical advances being introduced in
the surgical management of LSS, continues to pose a topic
of discussion among neurologists as well as orthopedic and
neurosurgeons as far as treatment strategies are concerned.
Especially the cases of moderate or “soft” stenosis, very
different than the bony or consolidated type, warrant a detailed
analysis of the primary interspinous devices used for both
types along with a proposal for a decision-making protocol.
Based on our experience with the management of these two
entities, we will focus on our results and future considerations
with less invasive procedures which are proving over the last
two decades to be a viable alternative for stenosis patients.
Core of our presentation are our results with a minimal invasive
procedure performed in 121 patients and their corresponding
initial follow-up over 1 year with a 92% success rate evaluated
by an independent observer. This is clearly in contrast with the
40-90% success rates and 14-35% complication rates reported
and associated with standard decompression surgeries.
Furthermore,wewillpresentourconsiderationsofafurthernovel
technique and the direction treatment options are developing
towards with the corresponding scheduled clinical trial.
Speaker Biography
Walter Bini has completed his diploma at Westminster School, Simsbury Conn,
USA and post-graduate degree at Universidad de Zaragoza, Facultad de Medicina,
Zaragoza-Spain. In 2014, he was the Middle East Chairman of ISLASS. He was
head of Neurosurgery at Sheikh Khalifa General Hospital, UAQ-UAE from 2014-
2016. Currently, he is Consultant Neurosurgeon in Orthopedic Department,
spine section of Lanzo Hospital COF, Lanzo d’Intelvi in Italy and also visiting
consultant Neurosurgeon in Orthopedic Department at Healthpoint Hospital,
UAE. Currently he is Neurosurgeon at Waldkrankenhaus Bad Duben, Germany.
e
:
binidr4@gmail.com